Will marijuana be rescheduled? — Lowered from Schedule I
Markets
Every market on this event, moneyline first. Select one to compare it across platforms in the side panel.
| Outcome | Best | Volume | Azuro | Gemini | Kalshi | Limitless | Novig | Polymarket | Polymarket US |
|---|---|---|---|---|---|---|---|---|---|
Before Jan 20, 2029 Favorite | 80.0%Kalshi | $62.6K | — | — | — | — | — | — | |
Before Jan 1, 2028 | 71.0%Kalshi | $120.3K | — | — | — | — | — | — | |
Before Jan 1, 2027 | 8.6%Kalshi | $794.4K | — | — | — | — | — | — | |
Description from Kalshi. A cross-platform summary is generated once this event is matched across platforms.
If the DEA were to reschedule only certain cannabis derivatives or specific cannabinoids (e.g., move THC or a particular cannabis-derived pharmaceutical to a different schedule) without reclassifying marijuana/cannabis as a whole, that would not qualify as rescheduling marijuana for this contract. Ending the schedule altogether would resolve the market to Yes. Clarification (12/12/25): The Payout Criterion requires that marijuana is legally removed from Schedule I. The mere announcement or publication of a Final Rule in the Federal Register does not satisfy the Payout Criterion if the rule has not taken legal effect. The market resolves based on the actual status of the Schedules under the Controlled Substances Act.
Discussion (0)
Log in to join the discussion.
No comments yet — start the discussion.